Affordable Access

Publisher Website

Receptor Pharmacology

Authors
Publisher
Elsevier Inc.
Identifiers
DOI: 10.1016/s1054-3589(05)52003-9
Disciplines
  • Biology
  • Design
  • Pharmacology

Abstract

Publisher Summary Despite a clear evidence for a distinct amylin pharmacology and the localization of such pharmacology to sites such as the nucleus accumbens, efforts to clone an amylin receptor were fruitless for over a decade. This enigma led many to doubt the status of amylin as a bona fide hormone. The enigma of the amylin receptor was solved following the identification of receptor activity modifying proteins (RAMPs). These single transmembrane spanning molecules, when associated with a calcitonin receptor, altered its pharmacology from calcitonin-preferring to amylin-preferring. The newly designated amylinomimetic drug class has been defined on the basis of its unique pharmacology prior to the molecular characterization of amylin receptors. Currently, the class includes any agent that acts as an agonist at characterized amylin receptors. Several peptides, typically analogs of truncated salmon calcitonin, have been developed as potent and selective amylin antagonists and have been useful in identifying amylinergic responses.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

The pharmacology of the 5-HT4 receptor.

on International clinical psychop... November 1993

Receptor pharmacology.

on Advances in pharmacology (San... 2005

[Receptor theory in pharmacology].

on Die Medizinische Welt Apr 01, 1967

GABAA receptor pharmacology.

on Pharmacology & Therapeutics 1996
More articles like this..